ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.676,41
1,61%
S&P 500
5.599,30
0,49%
Dow Jones
41.350,93
-0,20%
Euro vs US Dollar
1,08875
0,02%
Bitcoin
83.314,41
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Curis Inc (CRIS) Börsenkurse

Curis Inc

Curis Inc (CRIS)

NASDAQ
2,63
-0,03
(-1,13%)
Geschlossen 13 März 9:00PM
Verzögert um 15 Minuten
2,63
0,00
(0,00%)
Nach Börsenschluss: 12:22AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
2,63
Gebot
2,50
Fragen
3,45
Volumen
29.975
2,61 Tagesbereich 2,7761
2,57 52-Wochen-Bereich 17,49
Marktkapitalisierung
22,268M
Handelsende
2,66
Handelsbeginn
2,7761
Letzte Trade
5
@
2.6
Letzter Handelszeitpunkt
Finanzvolumen
US$ 80.857
VWAP
2,6975
Durchschnittliches Volumen (3 Mio.)
108.259
Ausgegebene Aktien
8.466.957
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,47
Gewinn pro Aktie (EPS)
-5,6
Erlöse
10,02M
Nettogewinn
-47,41M

Über Curis Inc

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others... Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.curis.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Curis Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CRIS. The last closing price for Curis was US$2,66. Over the last year, Curis shares have traded in a share price range of US$ 2,57 to US$ 17,49.

Curis currently has 8.466.957 shares in issue. The market capitalisation of Curis is US$22,52 million. Curis has a price to earnings ratio (PE ratio) of -0.47.

CRIS Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
27 Februar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 Januar 2025
CRIS (-1,13%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.34-11.44781144782.973.152.57328942.84068311CS
4-0.55-17.29559748433.183.40942.57297142.98798188CS
12-0.85-24.42528735633.484.52.571082593.70654353CS
26-2.43-48.0237154155.066.442.57786094.00498488CS
52-7.82-74.832535885210.4517.492.57575625.55848827CS
156-56.57-95.557432432459.2612.5777750222.21538716CS
260-19.17-87.935779816521.83482.57155649297.44087837CS

CRIS - Frequently Asked Questions (FAQ)

What is the current Curis share price?
The current share price of Curis is US$ 2,63
How many Curis shares are in issue?
Curis has 8.466.957 shares in issue
What is the market cap of Curis?
The market capitalisation of Curis is USD 22,52M
What is the 1 year trading range for Curis share price?
Curis has traded in the range of US$ 2,57 to US$ 17,49 during the past year
What is the PE ratio of Curis?
The price to earnings ratio of Curis is -0,47
What is the cash to sales ratio of Curis?
The cash to sales ratio of Curis is 2,22
What is the reporting currency for Curis?
Curis reports financial results in USD
What is the latest annual turnover for Curis?
The latest annual turnover of Curis is USD 10,02M
What is the latest annual profit for Curis?
The latest annual profit of Curis is USD -47,41M
What is the registered address of Curis?
The registered address for Curis is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Curis website address?
The website address for Curis is www.curis.com
Which industry sector does Curis operate in?
Curis operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CRVOCervoMed Inc
US$ 6,15
(160,59%)
154M
ZENAZenaTech Inc
US$ 4,5505
(61,94%)
6,88M
OPRXOptimizeRx Corporation
US$ 6,265
(51,33%)
13,1M
SSPEW Scripps Company
US$ 2,05
(43,36%)
16,99M
GRPNGroupon Inc
US$ 13,9807
(43,10%)
10,42M
HITHealth In Tech Inc
US$ 1,32
(-82,31%)
16,78M
SPHLSpringview Holdings Ltd
US$ 1,24
(-79,33%)
11,08M
APDNApplied DNA Sciences Inc
US$ 0,0619
(-57,89%)
36,75M
ZYXIZynex Inc
US$ 3,39
(-51,57%)
4,05M
HEPAHepion Pharmaceuticals Inc
US$ 0,0488
(-41,90%)
81,09M
STISolidion Technology Inc
US$ 0,174899
(38,70%)
506,61M
NVDANVIDIA Corporation
US$ 115,74
(6,42%)
298,41M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,1432
(15,59%)
202,29M
VSTEVast Renewable Ltd
US$ 0,6182
(23,66%)
184,27M
CRVOCervoMed Inc
US$ 6,15
(160,59%)
154M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CRIS
Curis
USOTC
CAPC
Capstone Companies (QB)
BIT
S28720
Societe Generale Effekten
TG
A28W10
Apple
BIT
UC72PC
Unicredit Bank
BIT
1SQ
Block
COIN
OVCETH
OVCODE
TSXV
NICL
Nickel Rock Resources
TG
A3L74J
Asian Development Bank ADB
BIT
UC3F94
Unicredit Bank
TSXV
AQS.DB
Aequus Pharmaceuticals
TSXV
WAM
Western Alaska Minerals
AMEX
IDGT
iShares US Digital Infra...
COIN
SAXUSD
SOLA-X
NASDAQ
ZVSA
ZyVersa Therapeutics
BIT
UC3XA3
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten